Tokyo, April 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061145) titled 'Nationwide surveillance by the surveillance committee of Japanese Society of Chemotherapy, Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology and the Japanese Society for Infection Prevention and Control - Acute uncomplicated cystitis 2025-' on April 3.
Study Type:
Observational
Primary Sponsor:
Institute - The Committee of Four Academic Societies Joint Antimicrobial Susceptibility Surveillance Program
Condition:
Condition - Acute uncomplicated cystitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To determine the antimicrobial susceptibility of causative bacteria isolated from acute uncomplicated cystitis patients to various antimicrobial agents and clarify the antimicrobial resistance status.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 16
years-old
<=
Age-upper limit - Not applicable
Gender - Female
Key inclusion criteria - Acute uncomplicated cystitis
Key exclusion criteria - None
Target Size - 400
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 11 Month 13 Day
Date of IRB - 2025 Year 11 Month 13 Day
Anticipated trial start date - 2025 Year 11 Month 14 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069971
Disclaimer: Curated by HT Syndication.
